Anthraquinone-2-sulfonic acid (AQ2S) is a novel neurotherapeutic agent

Cell Death and Disease

Volumn 4, Issue 1, 2013, Pages

  Jackson, T C ^a   Verrier, J D ^a   Kochanek, P M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

AKT; anthraquinone; apoptosis; brain; caspase; neuroprotective

Indexed keywords

2 ANTHRAQUINONESULFONIC ACID; ALOIN; ANTHRAQUINONE DERIVATIVE; CASPASE 3; EMODIN; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RHEIN; SOMATOMEDIN C; STAUROSPORINE; UNCLASSIFIED DRUG; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ALLOIN; ANTHRAQUINONE SULFONATE; CASPASE; CHROMONE DERIVATIVE; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN INJURY; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE EXACERBATION; EMBRYO; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL DETECTION; ANIMAL; APOPTOSIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; NEUROBLASTOMA; OXIDATIVE STRESS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTHRAQUINONES; APOPTOSIS; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; EMODIN; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MORPHOLINES; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; STAUROSPORINE;

MLCS; MLOWN;

EID: 84872189366     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.187     Document Type: Article

References (60)

1. Greidanus J, Willemse PH, Uges DR, Oremus ET, De Langen ZJ, De Vries EG. Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review. Pharm Weekbl Sci 1988; 10: 237-245.
2. Patterson LH. Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-Activated cancer chemotherapy. Drug Metab Rev 2002; 34: 581-592. (Pubitemid 35006066)
3. Wald A. Is chronic use of stimulant laxatives harmful to the coloň J Clin Gastroenterol 2003; 36: 386-389.
4. Kumar A, Katiyar SB, Agarwal A, Chauhan PM. Perspective in antimalarial chemotherapy. Curr Med Chem 2003; 10: 1137-1150. (Pubitemid 36758227)
5. Winter RW, Cornell KA, Johnson LL, Ignatushchenko M, Hinrichs DJ, Riscoe MK. Potentiation of the antimalarial agent rufigallol. Antimicrob Agents Chemother 1996; 40: 1408-1411. (Pubitemid 26169997)
6. Martinelli V, Radaelli M, Straffi L, Rodegher M, Comi G. Mitoxantrone: benefits and risks in multiple sclerosis patients. Neurol Sci 2009; 30(Suppl 2): S167-S170.
7. Kingwell E, Koch M, Leung B, Isserow S, Geddes J, Rieckmann P et al. Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. Neurology 2010; 74: 1822-1826.
8. Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang Y, Hascher A et al. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. J Biol Chem 2005; 280: 3628-3635. (Pubitemid 40223830)
9. Liu T, Jin H, Sun QR, Xu JH, Hu HT. Neuroprotective effects of emodin in rat cortical neurons against beta-Amyloid-induced neurotoxicity. Brain Res 2010; 1347: 149-160.
10. Liu T, Hu HT, Sun QR. [Neuroprotective effects of emodin on primary rat cortical neurons apoptosis induced by hydrogen peroxide]. Zhong Yao Cai 2010; 33: 1116-1119.
11. Wang C, Zhang D, Ma H, Liu J. Neuroprotective effects of emodin-8-O-beta-D-glucoside in vivo and in vitro. Eur J Pharmacol 2007; 577: 58-63. (Pubitemid 47632528)
12. Convertino M, Pellarin R, Catto M, Carotti A, Caflisch A. 9,10-Anthraquinone hinders betaaggregation: how does a small molecule interfere with A beta-peptide amyloid fibrillatioň Protein Sci 2009; 18: 792-800.
13. Colombo R, Carotti A, Catto M, Racchi M, Lanni C, Verga L et al. CE can identify small molecules that selectively target soluble oligomers of amyloid beta protein and display antifibrillogenic activity. Electrophoresis 2009; 30: 1418-1429.
14. Kwon YS, Koh JY, Song DK, Kim HC, Kwon MS, Choi YS et al. Danthron inhibits the neurotoxicity induced by various compounds causing oxidative damages including betaamyloid (25-35) in primary cortical cultures. Biol Pharm Bull 2004; 27: 723-726.
15. Magrane J, Rosen KM, Smith RC, Walsh K, Gouras GK, Querfurth HW. Intraneuronal betaamyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 2005; 25: 10960-10969. (Pubitemid 41692626)
16. Yin KJ, Lee JM, Chen H, Xu J, Hsu CY. Abeta25-35 alters Akt activity, resulting in Bad translocation and mitochondrial dysfunction in cerebrovascular endothelial cells. J Cereb Blood Flow Metab 2005; 25: 1445-1455. (Pubitemid 41541955)
17. Frew T, Powis G, Berggren M, Abraham RT, Ashendel CL, Zalkow LH et al. A multiwell assay for inhibitors of phosphatidylinositol-3-kinase and the identification of natural product inhibitors. Anticancer Res 1994; 14: 2425-2428.
18. Olsen BB, Bjorling-Poulsen M, Guerra B. Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action. Int J Biochem Cell Biol 2007; 39: 227-237. (Pubitemid 44548449)
19. Su YT, Chang HL, Shyue SK, Hsu SL. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 2005; 70: 229-241.
20. Lai JM, Chang JT, Wen CL, Hsu SL. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Eur J Pharmacol 2009; 623: 1-9.
21. Perry SW, Norman JP, Litzburg A, Gelbard HA. Antioxidants are required during the early critical period, but not later, for neuronal survival. J Neurosci Res 2004; 78: 485-492. (Pubitemid 39536492)
22. Vincent AM, Mobley BC, Hiller A, Feldman EL. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 2004; 16: 407-416. (Pubitemid 38765100)
23. Hung KS, Tsai SH, Lee TC, Lin JW, Chang CK, Chiu WT. Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats. J Neurosurg Spine 2007; 6: 35-46.
24. Heck S, Lezoualc'h F, Engert S, Behl C. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem 1999; 274: 9828-9835.
25. Schmitt TL, Klein H, Droge W. Hydrogen peroxide inhibits activity of the IGF-1 receptor kinase. Redox Rep 2006; 11: 105-109. (Pubitemid 44111105)
26. Davila D, Torres-Aleman I. Neuronal death by oxidative stress involves activation of FOXO3 through a two-Arm pathway that activates stress kinases and attenuates insulinlike growth factor I signaling. Mol Biol Cell 2008; 19: 2014-2025.
27. Zhong J, Lee WH. Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline. Neurochem Int 2007; 51: 398-404. (Pubitemid 47503461)
28. Koh JY, Wie MB, Gwag BJ, Sensi SL, Canzoniero LM, Demaro J et al. Staurosporineinduced neuronal apoptosis. Exp Neurol 1995; 135: 153-159.
29. Krohn AJ, Preis E, Prehn JH. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J Neurosci 1998; 18: 8186-8197. (Pubitemid 28464997)
30. Pike BR, Zhao X, Newcomb JK, Wang KK, Posmantur RM, Hayes RL. Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo-hippocampal cultures. J Neurosci Res 1998; 52: 505-520. (Pubitemid 28252732)
31. Deshmukh M, Johnson EM Jr. Staurosporine-induced neuronal death: multiple mechanisms and methodological implications. Cell Death Differ 2000; 7: 250-261. (Pubitemid 30192974)
32. Kang KH, Lee KH, Kim MY, Choi KH. Caspase-3-mediated cleavage of the NF-kappa B subunit p65 at the NH2 terminus potentiates naphthoquinone analog-induced apoptosis. J Biol Chem 2001; 276: 24638-24644.
33. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003; 10: 76-100. (Pubitemid 36511834)
34. Leitao JM, Esteves da Silva JC. Firefly luciferase inhibition. Pharm Weekbl Sci 2010; 101: 1-8.
35. Thorne N, Auld DS, Inglese J. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol 2010; 14: 315-324.
36. Maddigapu PR, Bedini A, Minero C, Maurino V, Vione D, Brigante M et al. The pHdependent photochemistry of anthraquinone-2-sulfonate. Photochem Photobiol Sci 2010; 9: 323-330.
37. Jenkins LW, Peters GW, Dixon CE, Zhang X, Clark RS, Skinner JC et al. Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. J Neurotrauma 2002; 19: 715-740. (Pubitemid 34761335)
38. Carloni S, Girelli S, Buonocore G, Longini M, Balduini W. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 2009; 220: 82-89.
39. Dhandapani KM, Wade FM, Wakade C, Mahesh VB, Brann DW. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. J Neurochem 2005; 95: 9-19. (Pubitemid 41384421)
40. Zhang X, Chen Y, Ikonomovic MD, Nathaniel PD, Kochanek PM, Marion DW et al. Increased phosphorylation of protein kinase B and related substrates after traumatic brain injury in humans and rats. J Cereb Blood Flow Metab 2006; 26: 915-926. (Pubitemid 43980408)
41. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005; 25: 9794-9806. (Pubitemid 41510919)
42. Shein NA, Tsenter J, Alexandrovich AG, Horowitz M, Shohami E. Akt phosphorylation is required for heat acclimation-induced neuroprotection. J Neurochem 2007; 103: 1523-1529. (Pubitemid 47631815)
43. Zhan L, Wang T, Li W, Xu ZC, Sun W, Xu E. Activation of Akt/FoxO signaling pathway contributes to induction of neuroprotection against transient global cerebral ischemia by hypoxic pre-conditioning in adult rats. J Neurochem 2010; 114: 897-908.
44. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol 2000; 13: 135-160. (Pubitemid 30169958)
45. Ravati A, Ahlemeyer B, Becker A, Krieglstein J. Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res 2000; 866: 23-32. (Pubitemid 30313004)
46. Zhou X, Wang L, Wang M, Xu L, Yu L, Fang T et al. Emodin-induced microglial apoptosis is associated with TRB3 induction. Immunopharmacol Immunotoxicol 2011; 33: 594-602.
47. Lee YJ, Shacter E. Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 2000; 29: 684-692.
48. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 1997; 414: 552-556. (Pubitemid 27390666)
49. Moore JD, Rothwell NJ, Gibson RM. Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent. Br J Pharmacol 2002; 135: 1069-1077. (Pubitemid 34214467)
50. Goswami R, Kilkus J, Dawson SA, Dawson G. Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-Apoptotic stimuli. J Neurosci Res 1999; 57: 884-893. (Pubitemid 29416119)
51. Holton H. Soda Additive Softwood Pulping - Major New Process. Pulp Pap-Canada 1977; 78: 19-24.
52. Ziderman II, Belayche J. Effect of anthraquinones on endwise degradation of hydrocellulose in relation to alkaline pulping. Carbohyd Polym 1986; 6: 109-119.
53. Bien H-S, Stawitz J, Wunderlich K. Anthraquinone dyes and intermediates. Ullmann's Encyclopedia of Industrial Chemistry. 2000.
54. Leskovac V, Trivic S, Peggins JO. Primary toxic effects of anthraquinone-2-sulfonic acid in rat liver microsomes. Toxicol Lett 1995; 78: 107-110.
55. Adams GE, Clarke ED, Jacobs RS, Stratford IJ, Wallace RG, Wardman P et al. Mammalian cell toxicity of nitro compounds: dependence upon reduction potential. Biochem Biophys Res Commun 1976; 72: 824-829.
56. Bayol-Denizot C, Daval JL, Netter P, Minn A. Xenobiotic-mediated production of superoxide by primary cultures of rat cerebral endothelial cells, astrocytes, and neurones. Biochim Biophys Acta 2000; 1497: 115-126. (Pubitemid 30330896)
57. Winterbourn CC. Cytochrome c reduction by semiquinone radicals can be indirectly inhibited by superoxide dismutase. Arch Biochem Biophys 1981; 209: 159-167.
58. Fulbright JM, Huh W, Anderson P, Chandra J. Can anthracycline therapy for pediatric malignancies be less cardiotoxic? Curr Oncol Rep 2010; 12: 411-419.
59. Vile GF, Winterbourn CC. Microsomal reduction of low-molecular-weight Fe3chelates and ferritin: enhancement by adriamycin, paraquat, menadione, and anthraquinone 2- sulfonate and inhibition by oxygen. Arch Biochem Biophys 1988; 267: 606-613. (Pubitemid 19020351)
60. Jackson TC, Verrier JD, Semple-Rowland S, Kumar A, Foster TC. PHLPP1 splice variants differentially regulate Akt and PKCalpha signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus. J Neurochem 2010; 115: 941-955.